Haploidentical hematopoietic stem cell transplantation can lead to viral clearance in severe combined immunodeficiency - 30/05/13
Doi : 10.1016/j.jaci.2013.03.036
Mary Slatter, MD a, b 
, Zohreh Nademi, PhD a, Sanjay Patel, MD a, Dawn Barge, PhD c, Manoj Valappil, MD d, Ken Brigham, MPhil e, Sophie Hambleton, PhD a, b, Julia Clark, MD a, b, Terence Flood, MD a, Andrew Cant, MD a, b, Mario Abinun, DSc a, b, Andrew Gennery, MD a, b
, Zohreh Nademi, PhD a, Sanjay Patel, MD a, Dawn Barge, PhD c, Manoj Valappil, MD d, Ken Brigham, MPhil e, Sophie Hambleton, PhD a, b, Julia Clark, MD a, b, Terence Flood, MD a, Andrew Cant, MD a, b, Mario Abinun, DSc a, b, Andrew Gennery, MD a, b a Department of Paediatric Immunology, Newcastle University, Newcastle upon Tyne, United Kingdom
b Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
c Regional Immunology Laboratory, Newcastle upon Tyne, United Kingdom
d Newcastle upon Tyne Hospitals NHS Foundation Trust Health Protection Agency, Newcastle upon Tyne, United Kingdom
e Haematopoietic Stem Cell Laboratory, Newcastle upon Tyne, United Kingdom
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 131 - N° 6
P. 1705 - juin 2013 Retour au numéro
Article précédent
- Approved and unapproved use of immunoglobulins in Iceland
- Bryndís Ester Ólafsdóttir, Davíð Þór Þorsteinsson, Rannveig Einarsdóttir, Björn Rúnar Lúðvíksson, Gerður Gröndal, Kristján Erlendsson, Ásgeir Haraldsson
- Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations
- Andras Bors, Dorottya Csuka, Lilian Varga, Henriette Farkas, Attila Tordai, George Füst, Agnes Szilagyi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?